PROGRAM TABLETS FOR MEDIUM DOGS

Kraj: Australia

Język: angielski

Źródło: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Kup teraz

Ulotka dla pacjenta Ulotka dla pacjenta (PIL)
19-06-2017

Składnik aktywny:

LUFENURON

Dostępny od:

ELANCO AUSTRALASIA PTY LTD

INN (International Nazwa):

lufenuron(204.9mg/Tb)

Forma farmaceutyczna:

ORAL TABLET

Skład:

LUFENURON AMINE/AMIDE Active 204.9 mg/Tb

Sztuk w opakowaniu:

6 Tablets

Klasa:

VM - Veterinary Medicine

Wyprodukowano przez:

ELANCO AUSTRALASIA

Grupa terapeutyczna:

DOG | BITCH | CASTRATE | PUPPY

Dziedzina terapeutyczna:

PARASITICIDES

Wskazania:

FLEA | FLEA ALLERGIC DERMATITIS | CTENOCEPHALIDES SPP. | GROUND FLEAS

Podsumowanie produktu:

Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: DOG: [FLEA, FLEA ALLERGIC DERMATITIS]; For the prevention and lasting control of flea infestation and the treatment of flea allergic dermatitis in dogs weighing between 6.8 and 20 kg.

Status autoryzacji:

Registered

Data autoryzacji:

2023-07-01

Ulotka dla pacjenta

                                PRODUCT NAME
:
PROGRAM TABLETS FOR MEDIUM DOGS:
DATE
: Wednesday, 20 October 1999
PAGE
: 1 of 5
PACK SIZES
: 6 TABLETS
TYPE OF LABEL
: Carton, Blister and Leaflet
FILE
: progmd1.doc
VERSION
: 2
REASON
: Trans-Tasman harmonisation
Text above this line is not included in the actual label.
INFOPEST VERIFIES THAT THIS LABEL IS CONSISTENT WITH THE NRA
APPROVED TEXT LABEL OF 3/8/99 ________
Carton – Front panel
FOR ANIMAL TREATMENT ONLY
PROGRAM TABLETS FOR MEDIUM DOGS
Active Constituent: Each tablet contains 204.9 mg LUFENURON
Contents: 6 Tablets
For the prevention and lasting control of flea infestation and as an
aid in the control of flea
allergic dermatitis in dogs weighing between 6.8 and 20 kg
NOVARTIS Animal Health Australasia Pty Limited,
ACN 076 745 198
140-150 Bungaree Road, Pendle Hill, NSW 2145
Licensed under the Animal Remedies Act 1967 No.6451
Licensed to Novartis New Zealand Limited, 43-45 Patiki Road, Avondale,
Auckland .
PRODUCT NAME
:
PROGRAM TABLETS FOR MEDIUM DOGS:
DATE
: Wednesday, 20 October 1999
PAGE
: 2 of 5
PACK SIZES
: 6 TABLETS
TYPE OF LABEL
: Carton, Blister and Leaflet
FILE
: progmd1.doc
VERSION
: 2
REASON
: Trans-Tasman harmonisation
Text above this line is not included in the actual label.
Carton – Back panel
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
DIRECTIONS FOR USE
ADMINISTER ONE TABLET MONTHLY FOR DOGS BETWEEN 6.8 AND 20 KG
PROGRAM
must be given with a
FULL
meal. Either give
WITHIN
the food or
IMMEDIATELY
afterwards. It is essential that all dogs and cats in the household
(except unweaned puppies
or kittens), are treated for fleas with
PROGRAM.
For cats use
PROGRAM
suspension
(ARB No. 6452) and for dogs use
PROGRAM
tablets.
1.
BEFORE FLEAS ARE SEEN ON THE DOG.
For best results, start giving
PROGRAM
before flea activity is anticipated and
continue all year round.
2.
WHEN DOG IS ALREADY INFESTED WITH FLEAS.
PROGRAM
does not kill adult fleas. Where adult fleas are present, it will be
necessary to also treat the dog with a product registered for use
against adult fleas,
unti
                                
                                Przeczytaj cały dokument
                                
                            

Charakterystyka produktu

                                 
PRODUCT NAME: PROGRAM® TABLETS FOR MEDIUM 
DOGS
PAGE: 1 OF 5
 
SAFETY DATA SHEET 
Issued by: Novartis Animal Health Australasia Pty Ltd. 
Phone: 02 9805 3555 (office hours)
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
 
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER 
NOVARTIS ANIMAL HEALTH AUSTRALASIA PTY LTD.    
ABN 64 076 745 198
 
TELEPHONE 02 9805 3555 
(OFFICE HOURS)
54 WATERLOO RD 
FAX 02 9888 8387
NORTH RYDE, NSW  2113 
 
CHEMICAL NATURE:  
Lufenuron is a benzoylurea derivative. 
TRADE NAME:  
PROGRAM
®
 TABLETS FOR MEDIUM DOGS
 
PRODUCT USE:  
For the prevention and lasting control of flea infestation and as an
aid in the control of 
flea allergic dermatitis by once a month oral dose to
dogs weighing between 6.8 and 
20 kg. 
CREATION DATE: 
AUGUST, 2013 
THIS VERSION ISSUED: 
AUGUST, 2013 and is valid for 5 years from this date. 
SECTION 2 - HAZARDS IDENTIFICATION 
STATEMENT OF HAZARDOUS NATURE 
This product is classified as: 
 N, Dangerous to the environment.
Not classified as hazardous according to the 
criteria of SWA.  
Not a Dangerous Good according to the Australian Dangerous Goods
(ADG) Code. 
RISK PHRASES: 
 
R52. Harmful to aquatic organisms.  
SAFETY PHRASES:
 
 S25, S61. Avoid contact with eyes. Avoid release to the environment.
Refer to 
special instructions/Safety Data Sheets.  
SUSMP CLASSIFICATION:
 
 None allocated. 
ADG CLASSIFICATION:
 
 None allocated. Not a Dangerous Good under the ADG Code. 
UN NUMBER: 
 None allocated 
 
GHS SIGNAL WORD: NONE. NOT HAZARDOUS.  
HAZARD STATEMENT: 
H402: Harmful to aquatic life. 
PREVENTION 
P102: Keep out of reach of children. 
RESPONSE 
P353: Rinse skin or shower with water. 
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. 
P332+P313: If skin irritation occurs: Get medical advice. 
P337+P313: If eye irritation persists: Get medical advice. 
P391: Collect spillage. 
P370+
                                
                                Przeczytaj cały dokument